Genepath

Chatswood, Australia Founded: 2015 • Age: 11 yrs
Provides targeted gene sequencing for newborn screening and health detection.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 7 Brand Intelligence

About Genepath

Genepath is a company based in Chatswood (Australia) founded in 2015 by Glenn Bennett and Bennett Shum. It operates as a B2B and SaaS. Genepath offers products and services including Atlas. Genepath operates in a competitive market with competitors including Orchid, Immunosis, Private Genetic Health, The Gene Council and SafeDNA, among others.

  • Headquarter Chatswood, Australia
  • Founders Glenn Bennett, Bennett Shum
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Genepath

Genepath offers a comprehensive portfolio of products and services, including Atlas.

Product name locked
Category locked
Primary

Offers targeted gene sequencing for detecting treatable newborn conditions.

Funding Insights of Genepath

Premium access

Detailed funding history for Genepath

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Genepath

Investments
Premium access

Investment portfolio details for Genepath

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Genepath

Premium access

Detailed financials for Genepath

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Genepath Comparisons

Genepath Primary company
Description
Provides targeted gene sequencing for newborn screening and ...
Location
Chatswood, Australia
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Genepath

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Genepath

Genepath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orchid, Immunosis, Private Genetic Health, The Gene Council and SafeDNA, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Genetic screening services are provided for embryos and couples.
Locked Locked Locked
Developer of a diagnostic platform for diagnosing patients with immune dysfunctions
Locked Locked Locked
Provides genetic counselling, testing, and education for families with health conditions.
Locked Locked Locked
Offers private genetic testing and counselling for cancer risk, with online appointments and expert advice.
Locked Locked Locked
Offers genetic testing services and symptom matching for personalized health answers.
Premium access

Detailed competitors of Genepath

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Genepath

Premium access

Complete news archive for Genepath

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Genepath

Genepath was founded in 2015.

Genepath is headquartered in Chatswood, Australia. It is registered at Chatswood, New South Wales, Australia.

Genepath specializes in targeted genomic screening for newborns, utilizing the Atlas platform to perform efficient gene sequencing on bloodspot samples. It detects treatable childhood conditions with high throughput and cost-effectiveness. Based in Chatswood, Australia, the company focuses on preventive healthcare through customizable testing. Genepath supports integration into national screening programs, emphasizing accuracy and minimal uncertainties.

Genepath's top competitors include Orchid, Immunosis and Private Genetic Health.

Genepath offers Atlas.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available